CAPR Capricor Therapeutics Inc

Capricor Therapeutics Inc is a clinical stage biotechnology company developing products for the treatment of cardiovascular diseases with a focus on heart failure.

As of 06/24/2021     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  06/24/2002
Outstanding shares:  22,877,930
Average volume:  657,507
Market cap:   $130,861,760
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    14070B309
ISIN:        US14070B3096
Sedol:      BK7Y2Z3
Valuation   (See tab for details)
PE ratio:   -7.14
PB ratio:   3.27
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy